These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 15244522)
21. Elastosonographic evaluation of endometrium in women using tamoxifen for breast cancer. Gultekin IB; Imamoglu GI; Gultekin S; Yilmaz EA; Yilmaz Z; Alkan A; Kucukozkan T Niger J Clin Pract; 2019 Jan; 22(1):92-100. PubMed ID: 30666026 [TBL] [Abstract][Full Text] [Related]
22. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study. Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921 [TBL] [Abstract][Full Text] [Related]
23. Microwave endometrial ablation for endometrial protection in women with breast cancer on adjuvant tamoxifen. Zhu Y; Yang J J Obstet Gynaecol Res; 2013 Sep; 39(9):1411-4. PubMed ID: 23815697 [TBL] [Abstract][Full Text] [Related]
24. Uterine side effects of tamoxifen: a need for systematic pretreatment screening. Berlière M; Charles A; Galant C; Donnez J Obstet Gynecol; 1998 Jan; 91(1):40-4. PubMed ID: 9464718 [TBL] [Abstract][Full Text] [Related]
25. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology. Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080 [TBL] [Abstract][Full Text] [Related]
26. Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen. Bertelli G; Valenzano M; Costantini S; Rissone R; Angiolini C; Signorini A; Gustavino C Gynecol Oncol; 2000 Sep; 78(3 Pt 1):275-7. PubMed ID: 10985880 [TBL] [Abstract][Full Text] [Related]
27. [Changes in the endometrium in treatment of breast carcinoma with tamoxifen]. Reslová T; Tosner J; Vávrová I; Resl M Ceska Gynekol; 1997 Oct; 62(5):277-9. PubMed ID: 9600168 [TBL] [Abstract][Full Text] [Related]
28. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study. Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913 [TBL] [Abstract][Full Text] [Related]
29. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Cheng WF; Lin HH; Torng PL; Huang SC Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568 [TBL] [Abstract][Full Text] [Related]
30. [Some specifics of tamoxifen's effect on the endometrium in menopausal cancer patients]. Ashtrafian LA; Antonova IB; Chazova NL; Motskobili TA; Babaeva NA; Al'ditskiĭ IA Vopr Onkol; 2005; 51(2):200-5. PubMed ID: 16223001 [TBL] [Abstract][Full Text] [Related]
32. Errors in the measurement of endometrial depth using transvaginal sonography in postmenopausal women on tamoxifen: random error is reduced using saline instillation sonography. Ballard P; Tetlow R; Richmond I; Killick S; Purdie DW Ultrasound Obstet Gynecol; 2000 Apr; 15(4):321-6. PubMed ID: 10895453 [TBL] [Abstract][Full Text] [Related]
33. Value of the progesterone test in screening for endometrial pathology in asymptomatic postmenopausal women receiving treatment with tamoxifen. Lubian López DM; Fernandez YG; Rodríguez BR; López FM; Delgado RC Menopause; 2010; 17(3):487-93. PubMed ID: 20464783 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of endometrial changes and p53 expression in tamoxifen treated women: comparison of various methods. Pokharel HP; Bhatla N; Kriplani A; Mukhopadhyay A; Srivastava A; Ralhan R Kathmandu Univ Med J (KUMJ); 2006; 4(2):145-51. PubMed ID: 18603889 [TBL] [Abstract][Full Text] [Related]
35. Endometrial thickness and ovarian cysts as measured by ultrasound in asymptomatic postmenopausal breast cancer patients on various adjuvant treatments including tamoxifen. Lindahl B; Andolf E; Ingvar C; Liedman R; Ranstam J; Willén R Anticancer Res; 1997; 17(5B):3821-4. PubMed ID: 9427787 [TBL] [Abstract][Full Text] [Related]
36. Ultrasonography of the endometrium and endometrial pathology under tamoxifen treatment. Friedrich M; Villena-Heinsen C; Mink D; Endres V; Reitnauer K; Schmidt W Eur J Gynaecol Oncol; 1998; 19(6):536-40. PubMed ID: 10215436 [TBL] [Abstract][Full Text] [Related]
37. Endometrial tubal metaplasia in a young puerperal woman after breast cancer. Di Benedetto L; Giovanale V; Caserta D Int J Clin Exp Pathol; 2015; 8(6):7610-3. PubMed ID: 26261678 [TBL] [Abstract][Full Text] [Related]
38. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer. Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP Menopause; 2009; 16(2):293-300. PubMed ID: 19034048 [TBL] [Abstract][Full Text] [Related]
39. Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women. Marttunen MB; Cacciatore B; Hietanen P; Pyrhönen S; Tiitinen A; Wahlström T; Ylikorkala O Br J Cancer; 2001 Apr; 84(7):897-902. PubMed ID: 11286468 [TBL] [Abstract][Full Text] [Related]
40. Long-term "protective" effect of aromatase inhibitors on the endometrium of postmenopausal breast cancer patients. Markovitch O; Tepper R; Fishman A; Aviram R; Cohen I Breast Cancer Res Treat; 2009 Jan; 113(2):321-6. PubMed ID: 18297393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]